AJP - Lung AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 294: L178-L186, 2008. First published November 9, 2007; doi:10.1152/ajplung.00263.2007
1040-0605/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/L178    most recent
00263.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, G.
Right arrow Articles by Minshall, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, G.
Right arrow Articles by Minshall, R. D.

EDITORIAL FOCUS

Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury

Guochang Hu,1,3 Richard D. Ye,1 Mary C. Dinauer,4 Asrar B. Malik,1,3 and Richard D. Minshall1,2,3

Departments of 1Pharmacology and 2Anesthesiology and 3Center for Lung and Vascular Biology, University of Illinois College of Medicine, Chicago, Illinois; and 4Herman B. Wells Center for Pediatric Research, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana

Submitted 6 July 2007 ; accepted in final form 6 November 2007

Caveolin-1 present in immune cells may be involved in regulation of the inflammatory response. Here, using caveolin-1-null (Cav-1–/–) mice, we addressed the role of caveolin-1 in polymorphonuclear neutrophils (PMNs) in regulating PMN activation-mediated lung injury. In lungs of wild-type (Cav-1+/+) mice perfused at constant flow with Krebs-Henseleit solution, addition of Cav-1+/+ PMNs (4 x 106 cells) into the perfusate followed by their activation with formyl-Met-Leu-Phe (fMLP, 1.0 µM) plus platelet-activating factor (1.0 nM) increased pulmonary microvessel filtration coefficient by 150% and wet-to-dry lung weight ratio by 50% as well as PMN accumulation in lungs. These responses were markedly reduced in lungs perfused with Cav-1–/– PMNs followed by addition of the same activating agents. fMLP-stimulated adhesion of Cav-1–/– PMNs to pulmonary microvascular endothelial cells and migration of Cav-1–/– PMNs across endothelial monolayers were also impaired compared with Cav-1+/+ PMNs. Cav-1–/– PMNs showed 50–80% reduction in PMA- or fMLP-stimulated superoxide production compared with Cav-1+/+ PMNs. In addition, Cav-1–/– PMNs had decreased migratory activity (50%) and adhesion to fibrinogen (40%) in response to fMLP. Rac1 and Rac2 were activated in Cav-1+/+ PMNs after stimulation of fMLP but not in Cav-1–/– PMNs. Exogenous expression of caveolin-1 in COS-phox cells augmented the fMLP-induced Rac1 activation and superoxide production, indicating a direct role of caveolin-1 in the mechanism of superoxide production. Thus caveolin-1 expression in PMNs plays a key role in mediating PMN activation, adhesion, and transendothelial migration and in PMN activation-induced lung inflammation and vascular injury.

caveolae; permeability; edema; Rac



Address for reprint requests and other correspondence: G. Hu, Dept. of Pharmacology (m/c 868), Univ. of Illinois College of Medicine, 835 South Wolcott Ave., Chicago, IL 60612 (e-mail: gchu{at}uic.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.